In contrast, although ET-1 is also a biomarker implicated in the pathophysiological processes of heart failure and its plasma concentrations are generally increased both in heart failure with reduced ejection fraction and in heart failure with preserved ejection fraction and have a negative prognostic role, in our study, ET-1 level was not increased and was not associated with the stage of heart failure. The gene discussed is EDN1; the disease is heart failure.